Great Point Partners LLC Insmed Inc Transaction History

Great Point Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $11.6 Million - $36.6 Million	-525,585 Reduced 67.77%	250,000 $16.8 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $14.1 Million - $16.5 Million	549,673 Added 243.31%	775,585 $21 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $3.96 Million - $5.36 Million	-168,960 Reduced 42.79%	225,912 $7 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $7.84 Million - $10.6 Million	394,872 New	394,872 $9.97 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $1.33 Million - $3.31 Million	-97,359 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $1.57 Million - $2.43 Million	97,359 New	97,359 $2.33 Million

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.